Purpose: To verify the potential efficacy of intravitreal bevacizumab (IVB) injections for the treatment of retinal angiomatous proliferation (RAP).
Design: Retrospective interventional case series.
Methods: Four consecutive patients affected by RAP at different stages and refractory to photodynamic therapy (PDT).